Allakos Interest Debt Per Share Over Time

ALLK Stock

USD 1.03 0.02 1.98%

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.

Check out Allakos Performance and Allakos Correlation.

For more information on how to buy Allakos Stock please use our How to buy in Allakos Stock guide.

Interest Debt Per Share is expected to rise to 0.13 this year.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allakos. If investors know Allakos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allakos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.03)

Return On Assets

(0.49)

Return On Equity

(1.22)

The market value of Allakos is measured differently than its book value, which is the value of Allakos that is recorded on the company's balance sheet. Investors also form their own opinion of Allakos' value that differs from its market value or its book value, called intrinsic value, which is Allakos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allakos' market value can be influenced by many factors that don't directly affect Allakos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Allakos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allakos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allakos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Specify up to 10 symbols:

Apply

Cross Equities Interest Debt Per Share Analysis

Compare Allakos and related stocks such as Apellis Pharmaceuticals, Blueprint Medicines Corp, and Karuna Therapeutics Interest Debt Per Share Over Time

Select Fundamental

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
APLS	1.9095	1.9095	1.9095	1.9095	1.9095	1.9095	1.9095	1.9095	0.5434	2.4179	5.1723	2.3959	1.1814	1.0332	0.98
BPMC	0.2294	0.2294	0.2294	0.2294	0.7258	0.4406	0.1651	0.046	0.0017	0.4298	0.1455	0.1383	2.6131	11.2361	11.8
DAWN	0.0335	0.0335	0.0335	0.0335	0.0335	0.0335	0.0335	0.0335	0.0335	0.0335	5.0E-4	0.0034	0.0787	0.0051	0.0049
ATRA	0.4868	0.4868	0.4868	0.4868	0.4868	0.4868	0.4868	0.4868	0.4868	0.4868	0.4868	0.4868	0.4868	1.2475	0.7
FATE	0.5601	0.5601	0.4692	0.4288	0.9866	0.8028	0.3881	0.3829	0.295	0.0505	0.0407	0.0589	0.1185	0.0628	0.0596
SANA	0.3835	0.3835	0.3835	0.3835	0.3835	0.3835	0.3835	0.3835	0.3835	0.3835	0.3835	0.6666	0.5748	0.52	0.43
CRBU	0.0089	0.0089	0.0089	0.0089	0.0089	0.0089	0.0089	0.0089	0.0089	0.0089	0.0266	1.0E-4	0.0159	0.0183	0.0142
RCUS	0.1422	0.1422	0.1422	0.1422	0.1422	0.1422	0.1422	0.1422	0.1422	0.0037	0.0037	0.0037	0.0278	0.027	0.0257
RARE	0.0117	0.0117	0.1479	0.1479	0.1479	0.1479	0.1479	0.1479	0.1479	0.1479	0.6947	5.7861	0.7837	0.8975	1.11
CRNX	0.0161	0.0161	0.0161	0.0161	0.0161	0.0161	0.0161	6.0E-4	0.083	0.083	0.083	0.083	0.083	0.0747	0.0785
ARVN	0.0292	0.0292	0.0292	0.0292	0.0292	0.0292	0.0292	0.0174	0.2347	0.0633	0.0522	0.044	0.2782	0.0144	0.0137
RVMD	0.0028	0.0028	0.0028	0.0028	0.0028	0.0028	0.0028	0.0028	0.0032	0.0018	0.0011	0.0855	0.084	0.0678	0.0712
KURA	0.0052	0.0244	0.0347	0.045	17.9779	0.0089	0.4225	0.3437	0.2407	0.1926	0.1475	0.0062	0.1747	0.1692	0.16
NXTC	0.0857	0.0857	0.0857	0.0857	0.0857	0.0857	0.0857	0.0857	0.0458	0.3319	0.1328	0.0028	0.2381	0.2137	0.12
CTMX	0.1276	0.1276	0.1276	0.1276	0.0995	0.2015	0.0466	0.5486	0.5486	0.5486	0.4697	0.2815	0.2126	0.1893	0.19
SPRO	0.1171	0.1171	0.1171	0.1171	0.1171	0.1171	0.1171	0.1171	0.0189	0.0511	0.0423	0.1069	0.1143	0.0326	0.031
ASMB	87.9779	0.0607	0.0908	0.0908	0.0908	0.0908	0.0908	0.0908	0.0908	0.0908	0.0858	0.0677	0.8339	0.96	0.91
ALLO	0.116	0.116	0.116	0.116	0.116	0.116	0.116	0.116	0.116	0.116	0.116	0.116	0.116	0.1	0.096
HRTX	29.5407	0.0792	0.0893	0.1145	0.0935	0.0961	1.4654	0.6036	0.099	0.1103	0.1317	1.563	1.4186	1.3081	1.24
ANNX	9.3625	9.3625	9.3625	9.3625	9.3625	9.3625	9.3625	9.3625	9.3625	0.0314	0.0314	0.0314	0.0909	0.0286	0.0272
SGMO	0.0499	0.0123	0.0123	0.0123	0.0123	0.0123	0.0123	0.0123	0.0123	0.0123	0.0123	0.0123	0.0123	0.0142	0.0257

Allakos and related stocks such as Apellis Pharmaceuticals, Blueprint Medicines Corp, and Karuna Therapeutics Interest Debt Per Share description

My Equities

My Current Equities and Potential Positions

View All Next

Allakos

ALLK

Specialization	Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Location	California; U.S.A
Exchange	NASDAQ Exchange

USD 1.03

When determining whether Allakos is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Allakos Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Allakos Stock. Highlighted below are key reports to facilitate an investment decision about Allakos Stock:

How To Invest In Allakos

Details

Is Allakos Stock a good investment?

Details

What is Allakos' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Allakos Performance and Allakos Correlation.

For more information on how to buy Allakos Stock please use our How to buy in Allakos Stock guide.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Allakos technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Volatility Indicators

View

Value Movement

View

A focus of Allakos technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Allakos trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Allakos Interest Debt Per Share Over Time

Specify up to 10 symbols:

Cross Equities Interest Debt Per Share Analysis

Allakos and related stocks such as Apellis Pharmaceuticals, Blueprint Medicines Corp, and Karuna Therapeutics Interest Debt Per Share description

My Equities

My Current Equities and Potential Positions

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY